Investors
Key press releases
Cellectis is listed on the Nasdaq Global Market (ticker: CLLS) and on the Euronext Growth Paris (ticker: ALCLS).
Cellectis ADS (Nasdaq)
Ticker: CLLS
$2.6600
-0.0500 (-1.8450%)
- Prev. close
- 2.7100
- Volume
- 81,553
- High
- 2.8100
- Capitalization
- 191.769M
Cellectis (Euronext Growth Paris)
Ticker: ALCLS
€2.4350
+0.0050 (0.2058%)
- Prev. close
- 2.4300
- Volume
- 56,847
- High
- 2.4900
- Capitalization
- 175.548M
Covering research analysts
Barclays - Gena Wang
Bryan Garnier - Oscar Haffen-Lamm
Goldman Sachs - Salveen Richter
Jefferies - Kelly Shi
JMP Securities - Silvan Tuerkcan
Jones Trading - Soumit Roy
Kempen - Sebastiaan van der Schoot
Oddo BHF - Martial Descoutures
RW Baird - Jack Allen
Wells Fargo – Yanan Zhu
Cellectis contact information
Arthur Stril, Chief Financial Officer & Chief Business Officer
Citibank ADR contact information
Intermediaries & Investors
US: +1 212 723 5435
UK: +44 207 500 2030
Société Générale Securities Services - Ordinary Shares contact information
Call center in English and French
Monday to Friday from 8:30am to 6pm CEST
+33 (0)2 51 85 67 89